HeartSciences Inc

HSCS | Healthcare | NASDAQ
$2.95
+0.02 (+0.68%)

Key Metrics

Market Cap
$6.62M
P/E Ratio
-0.36
EPS
$-8.28
Beta
N/A
Dividend Yield
N/A
ROE
-111,152.00%
Current Ratio
1,465.11

Company Information

Industry
Medical Devices

About HeartSciences Inc

HeartSciences Inc a medical technology company focuses on applying AIbased technology to an ECG to expand and improve clinical usefulness It develops artificial intelligenceenhanced electrocardiography AIECG solutions an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease andor agerelated cardiac dysfunction MyoVista wavECG device a resting 12lead ECG that provides diagnostic information related to cardiac dysfunction as well as conventional ECG information in the same test and MyoVista Insights a cloudbased platform to host AIECG algorithms on an ECG hardware agnostic basis The company was formerly known as Heart Test Laboratories Inc and changed its name to HeartSciences Inc in October 2024 HeartSciences Inc was incorporated in 2007 and is headquartered in Southlake Texas

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-09-11 $-1.58 $-2.41 +-34.4%
2025-07-24 $-1.88 $-2.51 +-25.1%
2025-03-13 $-2.57 $-2.53 1.6%
2024-12-16 $-2.27 $-2.30 +-1.3%

Financial Ratios (TTM)

Gross Margin
61.74%
Operating Margin
-223,147.00%
Net Margin
-133,511.00%
ROA
-39.50%
Price to Book
1.22
Price to Sales
3.45